WLWT: Rare heart condition could be fatal for athletes

UC cardiologist discusses the impact of myocarditis

High school and college athletes are training differently in the midst of COVID-19. Athletic institutions are pulling back on starting sports to not only prevent the spread of COVID, but also a potentially deadly heart condition called myocarditis.

Richard Becker, MD, director the UC Heart, Lung and Vascular Institute, told WLWT that “exercise that is very, very high intensity or ultra-high intensity certainly could have an impact on a person's ability to fight infection.”

Myocarditis causes inflammation of the heart muscle, which is enlarged and weakened.  Scar tissue in the heart forces the muscle to work harder to circulate blood and oxygen throughout the body.

Listen to the interview with Dr. Richard Becker online.

Learn more about Dr. Becker’s research at UC. 

Related Stories

1

Sugar overload killing hearts

November 10, 2025

Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.

2

Is going nuclear the solution to Ohio’s energy costs?

November 10, 2025

The Ohio Capital Journal recently reported that as energy prices continue to climb, economists are weighing the benefits of going nuclear to curb costs. The publication dove into a Scioto Analysis survey of 18 economists to weigh the pros and cons of nuclear energy. One economist featured was Iryna Topolyan, PhD, professor of economics at the Carl H. Lindner College of Business.

3

App turns smartwatch into detector of structural heart disease

November 10, 2025

An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.